| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910633930303321 |
|
|
Autore |
Vogel Patric U. B. |
|
|
Titolo |
COVID-19: Search for a vaccine / / by Patric U. B. Vogel |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Wiesbaden : , : Springer Fachmedien Wiesbaden : , : Imprint : Springer Spektrum, , 2023 |
|
|
|
|
|
|
|
|
|
ISBN |
|
9783658389314 |
9783658389307 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed. 2023.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (60 pages) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Vaccines - Biotechnology |
Biomaterials |
Pharmacy |
Pharmaceutical chemistry |
Biomaterials-Vaccines |
Medicinal Chemistry |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Introduction -- Coronaviruses: history and viral properties -- Vaccine technologies, approaches against COVID-19, clinical phases -- Attenuated live vaccines -- Vector vaccines and virus-like particles -- Inactivated vaccines -- Recombinant proteins (protein subunits) -- Nucleic acid-based vaccines -- Other aspects - One vaccine for all? - Herd immunity - Duration of immunity - Sterilizing immunity -- Summary. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book presents the principle, strengths and weaknesses, and progress of various vaccine technologies against COVID-19. Additionally, important terms such as clinical phases, efficacy and sterilizing immunity are explained. In this second edition, the already approved vaccines are also presented and the importance of viral variants is explained. The content An introduction to the principle of vaccine technologies and their strengths and weaknesses The presentation of successes and failures of vaccines An overview of the currently ongoing vaccine projects against COVID-19 The target groups People with an interest in vaccines, viruses or infectious diseases |
|
|
|
|
|
|
|
|
|
|
People who want to better understand the current press releases on COVID-19 vaccine development. The author Patric U. B. Vogel is a biologist with many years of experience with various biopharmaceuticals, from live vaccines to DNA vaccines. He was a registered Qualified Person for several years and has regularly released coronavirus vaccines against animal diseases, among other things. Since 2019, he has been an author, trainer and consultant in the pharmaceutical field. This book is a translation of an original German edition. The translation was done with the help of artificial intelligence (machine translation by the service DeepL.com). A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation. |
|
|
|
|
|
| |